Common diabetes drug slows growth of normal cells carrying cancer mutation
10 set 2024 ·
6 min. 42 sec.
Scarica e ascolta ovunque
Scarica i tuoi episodi preferiti e goditi l'ascolto, ovunque tu sia! Iscriviti o accedi ora per ascoltare offline.
Descrizione
A common diabetes medication, metformin, slows the growth of precancerous cells in the oesophagus while some metabolic conditions accelerate it, suggests a new study. Researchers from the Wellcome Sanger Institute...
mostra di più
A common diabetes medication, metformin, slows the growth of precancerous cells in the oesophagus while some metabolic conditions accelerate it, suggests a new study.
Researchers from the Wellcome Sanger Institute discovered that metformin reduced the growth of potentially cancerous cells both in mice and laboratory experiments. The team also found that metabolic conditions such as diabetes and obesity could enhance the growth advantage of these altered cells in human samples.
The findings, recently published in Nature Genetics, highlight the potential role of metformin and overall metabolic health in managing squamous oesophageal cancer risk. Researchers suggest the drug may be beneficial beyond its role in diabetes, though more research is needed.
mostra meno
Researchers from the Wellcome Sanger Institute discovered that metformin reduced the growth of potentially cancerous cells both in mice and laboratory experiments. The team also found that metabolic conditions such as diabetes and obesity could enhance the growth advantage of these altered cells in human samples.
The findings, recently published in Nature Genetics, highlight the potential role of metformin and overall metabolic health in managing squamous oesophageal cancer risk. Researchers suggest the drug may be beneficial beyond its role in diabetes, though more research is needed.
Informazioni
| Autore | Wellcome Sanger Institute |
| Organizzazione | Wellcome Sanger Institute |
| Sito | - |
| Tag |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
